Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1962 1
1963 2
1964 1
1965 2
1967 1
1968 1
1969 2
1970 8
1971 4
1972 18
1973 20
1974 21
1975 86
1976 93
1977 89
1978 121
1979 130
1980 195
1981 166
1982 192
1983 222
1984 286
1985 315
1986 336
1987 386
1988 407
1989 501
1990 564
1991 562
1992 651
1993 706
1994 804
1995 774
1996 876
1997 1016
1998 1105
1999 1138
2000 1253
2001 1382
2002 1360
2003 1534
2004 1736
2005 1843
2006 2181
2007 2248
2008 2538
2009 2614
2010 3062
2011 3399
2012 3752
2013 4019
2014 4289
2015 4512
2016 4567
2017 4857
2018 5071
2019 5288
2020 6061
2021 6422
2022 6130
2023 6144
2024 4890

Text availability

Article attribute

Article type

Publication date

Search Results

92,647 results

Results by year

Filters applied: . Clear all
Page 1
Breast cancer in young women.
Radecka B, Litwiniuk M. Radecka B, et al. Ginekol Pol. 2016;87(9):659-663. doi: 10.5603/GP.2016.0062. Ginekol Pol. 2016. PMID: 27723074 Free article. Review.
Breast cancer (BC) in young women is rare, affecting only 4-6% of women under the age of 40. ...Recently, a significant increase in BC rates has been observed among pre-menopausal subjects. Breast cancer in young women requires special attention due to …
Breast cancer (BC) in young women is rare, affecting only 4-6% of women under the age of 40. ...Recently, a significant increa …
Estrogen and progesterone receptors in breast cancer.
Yip CH, Rhodes A. Yip CH, et al. Future Oncol. 2014 Nov;10(14):2293-301. doi: 10.2217/fon.14.110. Future Oncol. 2014. PMID: 25471040 Review.
Breast cancer is the most common cancer in women worldwide. The majority of breast cancers show overexpression of estrogen receptors (ERs) and progesterone receptors (PRs). ...In recent guidelines, the recommended definition of ER and PR positivity …
Breast cancer is the most common cancer in women worldwide. The majority of breast cancers show overexpression o …
Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights.
Anestis A, Zoi I, Papavassiliou AG, Karamouzis MV. Anestis A, et al. Molecules. 2020 Jan 15;25(2):358. doi: 10.3390/molecules25020358. Molecules. 2020. PMID: 31952272 Free PMC article. Review.
Biological insight into AR-positive breast cancer reveals that AR may cross-talk with several vital signaling pathways, including key molecules and receptors. AR exhibits different behavior depending on the breast cancer subtype. Preliminary cli …
Biological insight into AR-positive breast cancer reveals that AR may cross-talk with several vital signaling pathways, …
Screening for breast cancer in 2018-what should we be doing today?
Seely JM, Alhassan T. Seely JM, et al. Curr Oncol. 2018 Jun;25(Suppl 1):S115-S124. doi: 10.3747/co.25.3770. Epub 2018 Jun 13. Curr Oncol. 2018. PMID: 29910654 Free PMC article. Review.
To help oncologists and physicians provide optimal patient recommendations, the literature was reviewed to find the latest guidelines for screening mammography, including benefits and perceived harms of overdiagnosis, false positives, false negatives, and technologic advan …
To help oncologists and physicians provide optimal patient recommendations, the literature was reviewed to find the latest guidelines for sc …
Hormone receptor-positive breast cancer and black race: does sex matter?
Eskander MF, Li Y, Bhattacharyya O, Tsung A, Oppong BA, Hamad A, Gatti-Mays M, Obeng-Gyasi S. Eskander MF, et al. Breast Cancer Res Treat. 2021 Nov;190(1):111-119. doi: 10.1007/s10549-021-06359-5. Epub 2021 Aug 12. Breast Cancer Res Treat. 2021. PMID: 34383180 Free PMC article.
PURPOSE: Black breast cancer patients have worse clinical outcomes than their White counterparts. There are few studies comparing clinical outcomes between Black male breast cancer (MBC) and female breast cancer (FBC) patients. ...Hormone …
PURPOSE: Black breast cancer patients have worse clinical outcomes than their White counterparts. There are few studies compar …
Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
Wang Q, Zhao S, Gan L, Zhuang Z. Wang Q, et al. Biosci Rep. 2020 Sep 30;40(9):BSR20202537. doi: 10.1042/BSR20202537. Biosci Rep. 2020. PMID: 32830857 Free PMC article.
However, the analysis of the association between PITX1 expression and the survival in breast cancer remains unclear. METHODS: Clinical prognostic parameters and survival data related to PITX1 in breast cancer patients were performed using the bioinform …
However, the analysis of the association between PITX1 expression and the survival in breast cancer remains unclear. METHODS: …
More options for adjuvant treatment of HER2-positive breast cancer: How to choose wisely?
Trapani D, Rajasekar AKA, Mathew A. Trapani D, et al. Int J Cancer. 2019 Dec 1;145(11):2901-2906. doi: 10.1002/ijc.32418. Epub 2019 May 31. Int J Cancer. 2019. PMID: 31107981 Review.
Human epidermal growth factor receptor 2-positivity (HER2) has a prognostic and predictive role in breast cancer. Trastuzumab, an anti-HER2 therapy, has a crucial role in a curative setting in Stage I, II and III breast cancer. ...Newer dosing s …
Human epidermal growth factor receptor 2-positivity (HER2) has a prognostic and predictive role in breast cancer. Trast …
Clinicopathological Features and Survival for Low ER-positive Breast-cancer Patients.
He A, Zhou T. He A, et al. Altern Ther Health Med. 2022 Sep;28(6):36-41. Altern Ther Health Med. 2022. PMID: 35648695 Free article.
CONTEXT: Testing patients for estrogen-receptor (ER) expression has become an important factor in the prognosis and prediction of breast cancer. Many studies have shown that endocrine therapy has no benefit for breast-cancer patients with low ER (ER+) …
CONTEXT: Testing patients for estrogen-receptor (ER) expression has become an important factor in the prognosis and prediction of breast …
[ESR1 Mutation-Positive Recurrent Breast Cancer Successfully Treated with Letrozole plus Abemaciclib].
Terasawa R, Takashima Y, Hirata A, Kimura K, Morita S, Hayashi M. Terasawa R, et al. Gan To Kagaku Ryoho. 2023 Aug;50(8):901-903. Gan To Kagaku Ryoho. 2023. PMID: 37608417 Japanese.
Approximately 70% of breast cancers are estrogen receptor(ER)positive, an indication for endocrine therapy. The first choice of treatment for ER-positive metastatic recurrent breast cancer is endocrine therapy, which has relatively few side effe …
Approximately 70% of breast cancers are estrogen receptor(ER)positive, an indication for endocrine therapy. The first choice o …
Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasis.
McCaffrey RL, Thompson JL, Oudsema RH, Sciallis AP, Cobain EF, Sabel MS, Jeruss JS. McCaffrey RL, et al. J Surg Oncol. 2022 Jun;125(8):1218-1223. doi: 10.1002/jso.26840. Epub 2022 Mar 1. J Surg Oncol. 2022. PMID: 35230701
METHODS: We performed a 10-year retrospective analysis of T1 HER2+ breast cancer patients. Clinicopathologic characteristics were evaluated based on surgical nodal data. ...The majority (66%) of lymph node positive patients were clinically T1c. CONCLUSIONS: W …
METHODS: We performed a 10-year retrospective analysis of T1 HER2+ breast cancer patients. Clinicopathologic characteristics w …
92,647 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "positive breast cancer"